Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-23-005176

Options or other derivatives

  • Director acquired 22,123 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
ROOT JONATHAN D Director 2023-06-12 Grant or award · Stock Option (Right to Buy) +22,123 22,123 D: show line 1 in the form
Loading xslF345X04/primarydocument.xml…